You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

30 June 2022
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
27 June 2022
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
27 June 2022

COVID-19 vaccine batch release information is now available.

10 June 2022

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

19 May 2022
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
2 May 2022

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

8 February 2022

Find information on complying with the rules around advertising and importing COVID-19 vaccines

20 December 2021
Frequently asked questions for new sponsors in relation to the supply of disinfectant products.
27 August 2021
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
24 August 2021
Where suitable, TGA inspectors will undertake remote and/or hybrid Good Manufacturing Practice (GMP) domestic inspections during the COVID-19 pandemic.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us